N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

BACKGROUND AND HYPOTHESIS: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, yet a significant proportion of individuals on clozapine continue to experience disabling symptoms, despite being treated with an adequate dose. There is a need for adjunct treatments to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Neill, Erica, Rossell, Susan L, Yolland, Caitlin, Meyer, Denny, Galletly, Cherrie, Harris, Anthony, Siskind, Dan, Berk, Michael, Bozaoglu, Kiymet, Dark, Frances, Dean, Olivia M, Francis, Paul S, Liu, Dennis, Phillipou, Andrea, Sarris, Jerome, Castle, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673271/
https://www.ncbi.nlm.nih.gov/pubmed/35857752
http://dx.doi.org/10.1093/schbul/sbac065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673271/
https://www.ncbi.nlm.nih.gov/pubmed/35857752
http://dx.doi.org/10.1093/schbul/sbac065

Ejemplares similares